World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
112
Citations
42509
World Ranking
500
National Ranking
19

Medicine

D-Index
114
Citations
44524
World Ranking
4775
National Ranking
182

Anton Berns publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Anton Berns sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 250 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Anton Berns D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Anton Berns sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 112 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Research.com Recognitions

  • 2016 - Member of the National Academy of Sciences
  • 1999 - Member of Academia Europaea

Overview

Anton Berns is affiliated with the Antoni van Leeuwenhoek Hospital in the Netherlands. Their research primarily spans medicine as well as biochemistry, genetics, and molecular biology, with significant contributions across related subfields such as pulmonary and respiratory medicine, molecular biology, oncology, radiology, nuclear medicine, and imaging.

The scientist's work covers multiple main topics including advances in oncology and radiotherapy, lung cancer research studies, economic and financial impacts of cancer, cancer genomics and diagnostics, lung cancer treatments and mutations, neuroendocrine tumor research advances, and occupational and environmental lung diseases.

Anton Berns has published extensively in several prominent scientific journals. Frequent venues for publication include Molecular Oncology, Genes & Development, Nature Cancer, Journal of Thoracic Oncology, and Frontiers in Oncology.

Notable recent papers by Anton Berns include:

  • Cells of origin of lung cancers: lessons from mouse studies, 2020, Genes & Development
  • New Approaches to SCLC Therapy: From the Laboratory to the Clinic, 2020, Journal of Thoracic Oncology
  • FGFR1 Oncogenic Activation Reveals an Alternative Cell of Origin of SCLC in Rb1/p53 Mice, 2020, Cell Reports
  • Combined deletion of Bap1, Nf2, and Cdkn2ab causes rapid onset of malignant mesothelioma in mice, 2020, The Journal of Experimental Medicine
  • Preclinical Models of Malignant Mesothelioma, 2020, Frontiers in Oncology

The scientist collaborates frequently with a group of researchers including Michaël Baumann, Ulrik Ringborg, Julio E. Celis, M. V. Heitor, and Bengt Jönsson.

Awards received by Anton Berns include membership in the National Academy of Sciences in 2016 and membership of Academia Europaea in 1999.

Best Publications

  • Simplified mammalian DNA isolation procedure.

    Peter W. Laird;Alice Zijderveld;Koert Linders;Michael A. Rudnicki

  • Requirement for a functional Rb-1 gene in murine development

    A. R. Clarke;E. R. Maandag;M. Van Roon;N. M. T. Van Der Lugt

  • Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.

    Jonkers J;Meuwissen R;van der Gulden H;Peterse H

  • Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging

    Maarten van Lohuizen;Sjef Verbeek;Blanca Scheljen;Ellen Wientjens

  • Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum

    Silvia Marino;Marc Vooijs;Hanneke van der Gulden;Jos Jonkers

  • E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements

    Gretchen Bain;Els C.Robanus Maandag;David J. Izon;Derk Amsen

  • Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer

    Niels de Wind;Marleen Dekker;Anton Berns;Miroslav Radman

  • Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte–macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

    R Soiffer;T Lynch;M Mihm;K Jung

  • High efficiency gene targeting in mouse embryonic stem cells

    Anton Berns;Els Robanus Maandag;Hein te Riele

  • Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice.

    Paul Krimpenfort;Kim C. Quon;Wolter J. Mooi;Ate Loonstra

  • Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins

    Gaston G.M. Habets;Ellen H.M. Scholtes;David Zuydgeest;Rob A. van der Kammen

  • Predisposition to lymphomagenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors

    Maarten van Lohuizen;Sjef Verbeek;Paul Krimpenfort;Jos Domen

  • Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells

    Ate Loonstra;Marc Vooijs;H. Berna Beverloo;Bushra Al Allak

  • Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis

    Patrick W.B. Derksen;Xiaoling Liu;Francis Saridin;Hanneke van der Gulden

  • Homologous recombinatin in mammalian cells

    Robert M. Kay;Anton Berns;Paul J.A. Krimpenfort;Frank Pieper

  • Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs

    H te Riele;E R Maandag;A Berns

  • Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model

    Ralph Meuwissen;Sabine C Linn;R.Ilona Linnoila;John Zevenhoven

  • Cell of Origin of Small Cell Lung Cancer: Inactivation of Trp53 and Rb1 in Distinct Cell Types of Adult Mouse Lung

    Kate D. Sutherland;Natalie Proost;Inge Brouns;Dirk Adriaensen

  • For better or for worse: the role of Pim oncogenes in tumorigenesis.

    Martijn C. Nawijn;Andrej Alendar;Anton Berns

  • Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model

    Ralph Meuwissen;Sabine C. Linn;R. Ilona Linnoila;John Zevenhoven

Frequent Co-Authors

Jos Jonkers
Jos Jonkers Antoni van Leeuwenhoek Hospital
Maarten van Lohuizen
Maarten van Lohuizen Antoni van Leeuwenhoek Hospital
Lodewyk F. A. Wessels
Lodewyk F. A. Wessels Antoni van Leeuwenhoek Hospital
Marc Vooijs
Marc Vooijs Maastricht University
John Allen
John Allen Coventry University
Peter W. Laird
Peter W. Laird Van Andel Institute
David J. Adams
David J. Adams Wellcome Sanger Institute
Hans Bloemendal
Hans Bloemendal Radboud University
Alexander M.M. Eggermont
Alexander M.M. Eggermont Institut Gustave Roussy
Silvia Marino
Silvia Marino Queen Mary University of London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Genetics, there are several complementary fields and alternative degree options available online. Many healthcare professions intersect with genetics, offering dynamic and in-demand career pathways. Exploring programs like fast track medical lpn can be a practical way to enter the medical field quickly, with options to advance further in nursing or clinical roles.

If you're seeking nursing programs that streamline the admissions process, some schools offer a nursing school without entrance exam requirement. This can save time for career changers or those eager to start health science education without additional standardized testing.

For future leaders and administrators in genetics-related organizations or healthcare systems, affordability matters. The cheapest online mha programs make it possible to pursue managerial roles while balancing work and life commitments.

Those considering advanced research or teaching can explore the flexibility and lower cost of an online nursing doctorate. These degrees may incorporate genetics, research methods, and leadership, positioning graduates for top roles in healthcare and academia.

Best Scientists Citing Anton Berns

Trending Scientists

Recently Published Articles